Yujing Cheng

1.4k total citations
60 papers, 805 citations indexed

About

Yujing Cheng is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Yujing Cheng has authored 60 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in Yujing Cheng's work include Acute Myocardial Infarction Research (14 papers), Cardiac Imaging and Diagnostics (12 papers) and Cardiovascular Function and Risk Factors (11 papers). Yujing Cheng is often cited by papers focused on Acute Myocardial Infarction Research (14 papers), Cardiac Imaging and Diagnostics (12 papers) and Cardiovascular Function and Risk Factors (11 papers). Yujing Cheng collaborates with scholars based in China, Spain and Taiwan. Yujing Cheng's co-authors include Yujie Zhou, Qi Zhao, Ying-Kai Xu, Yue Ma, Jiaqi Yang, Tingyu Zhang, Xiaoteng Ma, Xiaoli Liu, Yan Sun and Zhijian Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Molecules.

In The Last Decade

Yujing Cheng

54 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yujing Cheng China 12 370 280 155 145 133 60 805
April Kinninger United States 11 212 0.6× 153 0.5× 297 1.9× 48 0.3× 173 1.3× 76 684
Μanolis Vavuranakis Greece 14 326 0.9× 67 0.2× 201 1.3× 120 0.8× 103 0.8× 61 752
Wenkai Xiao China 17 348 0.9× 100 0.4× 107 0.7× 88 0.6× 44 0.3× 47 921
Soumaya Ben‐Aicha Spain 14 176 0.5× 108 0.4× 186 1.2× 119 0.8× 34 0.3× 37 711
Seongmin Kim South Korea 17 68 0.2× 136 0.5× 202 1.3× 72 0.5× 92 0.7× 66 841
D. Baron Australia 12 578 1.6× 146 0.5× 390 2.5× 113 0.8× 126 0.9× 35 942
Shiwei Yang China 17 201 0.5× 132 0.5× 294 1.9× 94 0.6× 43 0.3× 59 766
Kazuhiko Kotani Japan 15 182 0.5× 68 0.2× 149 1.0× 39 0.3× 35 0.3× 50 597

Countries citing papers authored by Yujing Cheng

Since Specialization
Citations

This map shows the geographic impact of Yujing Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujing Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujing Cheng more than expected).

Fields of papers citing papers by Yujing Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujing Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujing Cheng. The network helps show where Yujing Cheng may publish in the future.

Co-authorship network of co-authors of Yujing Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yujing Cheng. A scholar is included among the top collaborators of Yujing Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujing Cheng. Yujing Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ma, Xiaoteng, Yan Sun, Yujing Cheng, et al.. (2025). Effect of hyperhomocysteinemia on the prognostic value of triglyceride glucose index in patients with acute coronary syndrome. Frontiers in Cardiovascular Medicine. 11. 1517437–1517437. 1 indexed citations
3.
Zhang, Chan, et al.. (2025). ABCA4 regulates mitophagy in lung adenocarcinoma progression via AMPK pathway by modulating TMSB4X. International Immunopharmacology. 163. 115305–115305.
5.
Han, Hongya, Xiaoli Liu, Zhijian Wang, et al.. (2024). The synergistic effect of the atherogenic index of plasma and hyperuricemia on the prediction of coronary chronic total occlusion lesion: an observational cross-sectional study. Frontiers in Cardiovascular Medicine. 11. 1437096–1437096. 1 indexed citations
6.
Ma, Xiaoteng, Yan Sun, Yujing Cheng, et al.. (2024). The effect of hsCRP on TyG index-associated cardiovascular risk in patients with acute coronary syndrome undergoing PCI. Scientific Reports. 14(1). 18083–18083. 7 indexed citations
7.
Cheng, Yujing, et al.. (2024). Multiple machine-learning tools identifying prognostic biomarkers for acute Myeloid Leukemia. BMC Medical Informatics and Decision Making. 24(1). 2–2. 7 indexed citations
8.
Zhang, Chan, et al.. (2023). IL1RL1 polymorphisms rs12479210 and rs1420101 are associated with increased lung cancer risk in the Chinese Han population. Frontiers in Genetics. 14. 1183528–1183528. 3 indexed citations
9.
Sun, Jian, Yujing Cheng, Xiaoqiu Wang, et al.. (2023). Genome-wide assessment of genetic diversity and association mapping for salt tolerance traits in okra (Abelmoschus esculentus L. Moench) using genotyping-by-sequencing. Scientia Horticulturae. 313. 111922–111922. 4 indexed citations
10.
Zhao, Ziwei, Chi Liu, Qi Zhao, et al.. (2022). Triglyceride-glucose index and non-culprit coronary plaque characteristics assessed by optical coherence tomography in patients following acute coronary syndrome: A cross-sectional study. Frontiers in Cardiovascular Medicine. 9. 1019233–1019233. 5 indexed citations
11.
Zhang, Chan, et al.. (2022). Variants in CYP2J2 and CYP2C9 Contribute to Susceptibility of Lung Cancer. Current Cancer Drug Targets. 25(12). 1568–1577. 3 indexed citations
12.
Zhang, Chan, et al.. (2022). Association of CYP19A1 rs28757157 polymorphism with lung cancer risk in the Chinese Han population. World Journal of Surgical Oncology. 20(1). 400–400. 1 indexed citations
13.
Hu, Chengping, Jinxing Liu, Hongya Han, et al.. (2021). A Synergistic Effect of Lp(a) and GRACE Score on Cardiovascular Risk in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Cohort Study From China. Frontiers in Cardiovascular Medicine. 8. 637366–637366. 5 indexed citations
15.
Zhao, Qi, Tingyu Zhang, Yujing Cheng, et al.. (2020). Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes. Current Vascular Pharmacology. 19(1). 91–101. 6 indexed citations
16.
Zhao, Qi, Tingyu Zhang, Yujing Cheng, et al.. (2020). Impacts of geriatric nutritional risk index on prognosis of patients with non-ST-segment elevation acute coronary syndrome: Results from an observational cohort study in China. Nutrition Metabolism and Cardiovascular Diseases. 30(10). 1685–1696. 25 indexed citations
17.
Zhao, Qi, Tingyu Zhang, Yujing Cheng, et al.. (2020). Prognostic impact of estimated remnant-like particle cholesterol in patients with differing glycometabolic status: an observational cohort study from China. Lipids in Health and Disease. 19(1). 179–179. 13 indexed citations
18.
Ma, Xiaoteng, Lisha Dong, Qiaoyu Shao, et al.. (2020). Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Cardiovascular Diabetology. 19(1). 31–31. 152 indexed citations
19.
Ma, Xiaoteng, Qiaoyu Shao, Lisha Dong, et al.. (2020). Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Medicine. 99(30). e21321–e21321. 9 indexed citations
20.
Zhang, Chan, et al.. (2019). Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China. Molecular Genetics & Genomic Medicine. 7(5). e574–e574. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026